A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC

PHASE3RecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

March 31, 2030

Study Completion Date

March 31, 2030

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
RADIATION

Chemoradiotherapy

Chemoradiotherapy

Trial Locations (1)

Unknown

RECRUITING

National Cancer Center Hospital, Tokyo

All Listed Sponsors
lead

National Cancer Center, Japan

OTHER_GOV

NCT04328948 - A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC | Biotech Hunter | Biotech Hunter